Companies that own CSL Ltd.
BlackRock Fund Advisors
12,592,052
2.78%
44,902
0.1%
03/07/2017
The Vanguard Group, Inc.
11,654,269
2.58%
116,142
0.06%
07/31/2018
Capital Research & Management Co. (World Investors)
5,809,500
1.28%
-14,000
0.13%
06/30/2018
Fidelity Management & Research Co.
5,654,817
1.25%
-288,843
0.09%
07/31/2018
Norges Bank Investment Management
4,664,064
1.03%
587,726
0.11%
12/31/2017
First State Investment Management (UK) Ltd.
3,936,073
0.87%
6,322
2.93%
01/31/2018
BlackRock Investment Management (Australia) Ltd.
3,616,399
0.8%
900
2.8%
03/07/2017
Vanguard Investments Australia Ltd.
3,280,842
0.73%
51,811
1.11%
07/31/2018
BlackRock Advisors (UK) Ltd.
3,086,995
0.68%
-192,932
0.21%
03/07/2017
OppenheimerFunds, Inc.
2,962,259
0.66%
-125,700
0.28%
05/31/2018
| Address |
45 Poplar Road
Parkville Victoria (VIC) 3052
Australia
|
|
Employees
|
- |
| Website |
http://www.csl.com.au |
| Updated |
07/08/2019 |
| CSL Ltd. is a biopharmaceutical company, which engages in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma. |
